Healio
Healio
21003793_EF156_THin_MM_collection_banner

Take Homes in Multiple Myeloma
BySandra Mazzoni, DO
ByMarley V. Ghizzone
Fact checked byMindy Valcarcel, MS

Read more

July 05, 2024
2 min watch
Save

VIDEO: MRD testing a hot topic in multiple myeloma

BySandra Mazzoni, DO
ByMarley V. Ghizzone
Fact checked byMindy Valcarcel, MS

CHICAGO — In this video, Sandra Mazzoni, DO, discusses the use of minimal residual disease, or MRD, testing in multiple myeloma.

“There’s a lot of hot topics right now in myeloma in general,” Mazzoni, hematologist with the Cleveland Clinic, said.

She highlighted updates using MRD testing as a surrogate marker in clinical trials. The findings were presented at ASCO Annual Meeting.

“I do think those are eventually going to be practice changing cause [sic] right now, there’s really no standardization for MRD testing in multiple myeloma,” Mazzoni said.

Reference:

  • Rodriguez-Otero P, et al. Abstract 7502. Presented at: ASCO Annual Meeting; May 31-June 4, 2024; Chicago.
Sources/Disclosures

Collapse
Source:

Healio Interviews

Disclosures: Mazzoni reports consulting for Janssen.

Read more about

multiple myeloma
minimal residual disease
 

Related Content